Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A trial comparing chemotherapy with no further treatment after surgery to remove sarcoma of the womb
This trial was for women who have had surgery to remove their womb to treat a type of cancer called leiomyosarcoma. The trial compared chemotherapy after surgery with no further treatment. Cancer Research UK supported this trial.
More about this trial
If you have your womb removed (a
Most women will remain cancer free, but sometimes the cancer does come back. If this happens, you may have chemotherapy. There are several chemotherapy drugs that doctors can use, including a combination of the 2 drugs gemcitabine and docetaxel (Taxotere), and another drug called doxorubicin.
In this trial, researchers wanted to see if having these chemotherapy drugs after surgery to remove leiomyosarcoma reduced the chance of the cancer coming back.
Summary of results
This trial closed early as the researchers were unable to get enough women to take part. Because of this the trial team are not able to produce any significant results.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Helen Hatcher
Cancer Research UK
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/11/051.